Glycan profiling unlocks the glycan code behind protein folding, immune evasion, and pathogenesis. Glycans are synthesized without a gene template, requiring orthogonal methods of high resolution to analyze. Hydrophilic interaction chromatography separates glycans, mass spectrometry determines accurate mass and linkage, and lectin arrays determine glycan motifs. With these methods, complex sugar microenvironments can be converted into biological information.
Glycan profiling encompasses a suite of methods that allow comprehensive analysis of the glycosylation state of a protein sample. The profiling of glycans is necessary because glycans are synthesized by templates and as such can vary greatly in their branching patterns, linkage angles, and sugar composition. Glycan analysis methods typically include separation techniques, mass spectrometry analysis, and glycan recognition technologies to help determine glycan structures on proteins. Advances in glycan profiling methods strive to increase throughput, sensitivity and allow structural characterization. Glycosylation has emerged as a key factor impacting protein function and drug activity.
Fig. 1 A representative workflow for mass spectrometry-based glycoproteomic analyses.1,5
Analysis of glycans requires dedicated methods because sugars are more diverse than linear biomolecules for which common analytical methods were established. Glycan synthesis occurs via non-template driven enzymatic processes mediated by glycosyltransferases and glycosidases enzymes which produce mixture of isoforms with same composition but different branching patterns and linkages. They also show diversity in anomeric form, level of sialylation and occupancy on glycoproteins. Analytical methods also face difficulty because glycans lack chromophores for direct detection methods and their stereochemical variation requires orthogonal approaches to separate them.
Table 1 Fundamental Challenges in Glycan Analysis and Corresponding Technical Requirements
| Analytical Challenge | Specific Technical Requirement | Strategic Implication |
| Structural heterogeneity | Orthogonal separation capability | Resolution of isomeric variants |
| Absence of chromophores | Chemical derivatization protocols | Enhanced detection sensitivity |
| Labile modifications | Mild analytical conditions | Preservation of native structures |
| Site-specific occupancy | Glycopeptide-level analysis | Localization of modifications |
Modern glycomics techniques involve strategic combinations of sample processing, separation techniques and detection technologies. For example, glycan analysis often begins with the release of glycans from proteins using enzymes or chemicals. Glycans may then be purified and chemically modified ("derivatized") prior to separation and detection. Glycan samples can be separated by hydrophilic interaction liquid chromatography, reversed-phase chromatography, and other chromatographic techniques depending on their polarity and size. Mass spectrometry detection can then provide detection and molecular weight information. Structural interpretation of glycan mass spectra can be accomplished by tandem mass spectrometry. Lectin arrays provide an alternative method to analyze glycans. Lectin arrays allow for glycan analysis without extensive sample processing and can be used to rapidly analyze large numbers of samples. Lectin array results can validate glycan separation and mass spectrometry data.
Selection of a glycan analysis technique should be guided by the goal of the analysis, sample limitations, and required information. Questions necessitating details on linkage types and branching structures likely need mass spectrometry-based approaches, often with chromatographic separation to analyze isomers. Other studies may only require the relative comparison of glycan structures which are already characterized and can utilize chromatography with fluorescent detection due to its good reproducibility and maturity of quantitation methods. Lectin arrays can also be useful when only knowledge of certain glycan features are needed, such as when screening samples for potential glycan biomarkers. There are many successful strategies that start with a fast glycan profiling technique for screening purposes and are followed by more in-depth structural analyses.
Glycan sample preparation is critical to successful glycan analysis. Complete release of carbohydrates from proteins and lipids while maintaining structural integrity is essential. Release techniques, derivitization methods, and purification techniques influence subsequent data analysis from chromatography or mass spectrometry runs. Without adequate sample preparation, incomplete carbohydrate profiling results even with the most advanced technologies.
Sample types for glycan profiling cover serum/plasma, tissue extracts, cell culture media, or purified proteins. Serum/plasma samples are most commonly used in clinical settings. The glycome composition is biased towards N-linked glycans on immunoglobulins and acute phase proteins in serum/plasma. Glycome profiles of tissue samples are richer in species and therefore represent cellular functions more comprehensively. Glycan profiles from cultured cells provide an advantage of studying the biosynthetic pathways under defined conditions; however, residual media can impact glycan species detected. When analyzing purified proteins, minimal sample handling is necessary, though it is desirable to use methods amenable to high-throughput analysis for glycoproteins of pharmaceutical interest.
Release of glycans can be achieved enzymatically or chemically. While enzymes can be selective for specific linkages, chemicals cleave all linkages indiscriminately. Because N-linked glycans are attached to proteins by asparagine linked glycosylamine bonds, they can be liberated enzymatically from the protein by treatment with peptide-N-glycosidase F, which hydrolyzes this linkage. The selective release of O-linked glycans is much more difficult because there are no broad specificity endoglycosidases available to accomplish this task. Chemical release of O-linked glycans proceeds by β-elimination under basic conditions. Unfortunately, under these same conditions the released glycans may suffer a degradation reaction known as peeling. Reductive β-elimination produces alditols, which cannot be labeled with a fluorophore downstream while non-reductive methods allow this subsequent detection step.
Fluorescent labelling by reductive amination: Due to the absence of chromophores and poor ionization efficiency of carbohydrates under mass spectrometric conditions, chromatographic detection of glycans usually necessitates chemical derivatization. One common method of labelling glycans to allow sensitive detection is reductive amination using a fluorescent or chromophoric label. The label is introduced through reaction with the reducing end sugar to form a Schiff base, followed by reduction to create a stable glycosylamine. Permthyslation: Addition of permethyl groups not only aids in MS detection by increasing ionization efficiency, but also allows linkage-specific analysis when combined with GC-MS techniques. Carbamate-based labels: Rapid labeling reaction kinetics allow for easy high-throughput preparation.
Degradation, incomplete recovery, or loss of heterogeneity during sample preparation will adversely affect glycan profile results. For example, incomplete deglycosylation will lead to an underestimate of glycan heterogeneity and relative abundance. Exposure to strong chemical conditions can cause peeling off of labile sialic acids or other core modifications that can falsely simplify glycan profiles. Inconsistent derivatization efficiency can lead to inaccurate quantitation. Biological samples should always be processed using conditions that have been optimized and standardized. Quality controls should be included on each sample run and may include an internal standard and technical replicates. Reliable glycan profiles from biological samples are critical for diagnostic or biotherapeutic glycan biomarker validation.
High-performance liquid chromatography (HPLC) is commonly used for glycan analysis because HPLC systems allow high-resolution separation of glycans with sensitive detection methods downstream. Glycan mixtures can be analyzed by several chromatographic techniques that separate glycans by hydrophilicity, charge, or size to help elucidate complex glycan structures. Modes of HPLC can be used to separate structural isomers. Additionally, fluorescence detection or mass spectrometric detection following HPLC allows for quantitation and qualification of glycans for use in quality control processes of biopharmaceutical products or clinical glycan biomarker applications.
HPLC separation mechanisms take advantage of variable interaction of carbohydrate analytes with chromatographic stationary phases under defined conditions of the mobile phase. Normal phase separations are based on partition of glycans between organic solvent-rich mobile phases and layers of water activated on polar stationary phases. Separation on reversed phase columns is also possible after derivatization takes advantage of hydrophobic interactions. Together these chromatographic modes can resolve complex mixtures of glycans according to monosaccharide identity, branch position, and linkage type.
Release N- and O-glycans are typically resolved using HILIC, which is the most widely used due to its ability to resolve structural isomers. For example, glycans that differ by branching, linkage position, or level of sialylation can be separated due to differences in their interaction with either an amide-bonded or zwitterionic stationary phase. Neutral and charged glycans can be analyzed on the same column allowing for separation of entire glycomes from either mammalian or microbial samples.
Another separation technique that can be employed is reversed-phase high-performance liquid chromatography (RP-HPLC). Glycans labeled with hydrophobic fluorescent molecules are often well-retained on reverse phase columns after derivatization. This enables separation of glycans after reductive amination with aromatic labels because the labeled glycans become hydrophobic enough to be retained on the alkyl-interaction stationary phase and allows separation by size and structure. This technique also yields improved MS compatibility with volatile mobile phase components and allows sensitive detection of minor glycans.
Detection of glycans often requires pre-column derivatization with chromophores or fluorophores because carbohydrates do not have native spectroscopic features that can be readily and sensitively detected. Detection of fluorescence after excitation at specific wavelengths allows sensitive detection of even trace amounts of glycans present in a sample. Ultraviolet absorbance detection can be used with glycans labeled with aromatic groups, although it is less sensitive. This method can be useful when a fluorescence detector is not available or when coupling UV absorbance with MS detection.
Absolute and relative quantitation of glycans can be achieved by HPLC after labeling with a fluorescent tag. Relative quantitation is easily performed by integration of the fluorescence peaks, as the peak areas are proportional to molar amounts due to stoichiometric tagging. Absolute quantitation is difficult due to the differing derivatization efficiencies for various glycans and incomplete reaction of labels with glycans. Moreover, glycans that differ structurally may co-elute without orthogonal chromatographic separation or MS confirmation, making it difficult to quantify specific glycans unambiguously.
A number of techniques are available to determine glycan composition and structure. Mass spectrometry has become the gold standard technique due to its sensitivity, accurate mass measurement, and ability to deduce structural elements through fragmentation patterns. Glycan mixtures can be profiled with great detail using mass spectrometry by ionizing the carbohydrates into gas phase ions then separating them based on their masses. Information about molecular weight obtained through MS is then used to assign glycan structures. Mass spectrometry has also been used in conjunction with chromatography separation or ion mobility techniques to assign linkage positions. It is an important tool in glycan research as well as quality control for biopharmaceuticals.
Electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI) are currently the two most widely used ionization techniques for glycans by mass spectrometry. In ESI, ions are formed from solution. Solutions are pumped through a high voltage source, which creates charged droplets. As solvent evaporates from the droplets, the charge repels until ions are released. Multiply charged ions are often formed, making ESI useful for analyzing high mass glycans while maintaining high mass accuracy. ESI allows labile modifications to remain intact on glycans, and interfaces directly with liquid chromatography separations. MALDI forms ions using a laser. A matrix is co-crystallized with glycans. As the matrix is irradiated, singly charged ions are formed. MALDI simplifies mass spectra due to the abundance of singly charged ions. MALDI is used for high-throughput analysis, and imaging mass spectrometry. MALDI tends to fragment more sialylated species compared to ESI under normal conditions.
Choice of mass analyzer impacts resolution, mass accuracy and throughput. Time-of-flight analyzers use flight time through field free regions to separate ions. These devices are fast and have large m/z ranges which is desirable for glycan profiling. Ion trap analyzers allow for multiple stages of fragmentation by repeatedly selecting and isolating a given mass. This property is useful when looking at specific glycans and getting detailed structural information. Orbitrap and Fourier transform ion cyclotron resonance mass analyzers have high mass accuracy and resolution. This allows users to be able to resolve glycans that have the same mass and determine elemental composition. Coupling quadrupole mass filters with high resolution mass analyzers allows users to focus on targeted glycans with high sensitivity and selectivity which is desirable for quantification.
MS/MS using tandem mass spectrometry remains the gold standard method for obtaining structural information about glycans, including composition, sequencing, and linkage information. Glycosidic bond cleavages formed during CID give information about sequence and branching through the monosaccharide residues while higher-energy collisional dissociation (HCD) can produce cross-ring fragments that give linkage information. Electron-transfer dissociation (ETD) or electron capture dissociation (ECD) cause fragmentation by radical processes that retain labile modifications and create cross-ring fragments. Methods such as ultraviolet photodissociation and electron excitation dissociation have also recently been applied.
Resolution of structurally isomeric glycans can be one of the biggest obstacles encountered when analyzing glycan mixtures. Compositionally identical glycans that differ in linkage still share the same molecular weight. Techniques such as ion mobility separate glycans based on their collision cross-sections in the gas phase. This is another way to separate glycans that share the same mass or co-elute from chromatography. If ion mobility coupled to mass spectrometry is used, anomers, linkage isomers, and positional isomers can be distinguished by their drift times. Modifications that change the mass of only one monosaccharide residue can also be used to aid in distinguishing isomers. Differential mobility can also be used if the glycans demonstrate different mobilities when exposed to an electrical field. Differences between isomers can be distinguished using chromatography, ion-mobility spectrometry or mass spectrometry based on characteristic fragmentations.
The high sensitivity of mass spectrometry allows absolute detection limits down into trace levels of glycan species present in complex mixtures and using minimal sample amounts. Mass spectrometry provides extensive molecular information such as accurate mass, isotopic abundance and fragmentation data to assist structure elucidation. This structural information can be obtained without prior knowledge of glycan species that may be present in the sample. Quantitation using mass spectrometry remains challenging due to variability in ionization efficiencies between glycan classes and matrix effects. Fragmentation schemes can be complex, requiring advanced bioinformatic tools for interpretation of spectra. Mixtures of isomers pose additional challenges for spectral assignment. Mass spectrometry alone may be insufficient to distinguish between stereochemical differences or anomeric linkages without the use of complementary techniques or derivitization methods.
Lectin arrays or lectin microarrays utilize the glycan specificities of lectins to analyze glycans. Advantages of lectin-based methods include minimal need for sample modification and the ability to analyze glycans without high-tech equipment. Lectin-based methods detect glycoproteins using the reversible, non-covalent bonding of lectins (proteins) to glycans for purification, detection or imaging purposes. Lectin arrays/microarrays can be used in various applications including research and diagnostics. Lectin based platforms have been used in affinity chromatography, lectin microarrays or chips, blotting applications, and even incorporated into biosensors.
Binding of lectins to glycans involves hydrogen bonds, van der Waals forces, and hydrophobic effects. Binding involves specificity for particular saccharide residues and glycosidic linkages. Lectin binding is reversible, unlike enzyme-substrate binding, and there may be high or low affinity binding based on the structural match between the glycan epitope and the lectin binding site. Lectins from plant sources such as legumes commonly bind to terminal monosaccharides or certain types of disaccharides. Lectins from animal sources tend to recognize complex glycans. Lectins can be used to selectively capture glycoproteins that contain the glycan structures to which the lectin will bind.
In a lectin microarray assay numerous lectin probes are attached to a solid surface allowing multiple glycan patterns from biological samples to be screened simultaneously using fluorescence or chemiluminescence-based readouts. Glycoproteins or cell lysates incubated on the array will have unique binding profiles based on their glycosylation. Lectin-ELISA assays immobilize a lectin and capture specific glycoforms before detection with an antibody. The resulting glycan profile can distinguish between normal and diseased states without needing to structurally define each glycan.
The simplicity of lectin assays comes at a cost. Lectins often bind to classes of structures rather than distinct epitopes. Cross-reactivity can therefore occur between glycans that share structural features. Additionally, some lectins can distinguish between α-2,3 and α-2,6 linkages of sialic acid, but cannot distinguish between different sialylated glycans. Even among lectins that will bind to a particular glycan, differences in affinity mean that some lectins will require multiple copies of the glycan within a glycoconjugate to ensure binding. For these reasons, it is difficult to definitively assign glycans based solely on lectin binding data.
Applications of lectin-based glycan profiling are broad in clinical specimens including biomarker discovery platforms such as identifying disease-specific changes in glycosylation patterns that may be used to aid in diagnosis of cancers and other diseases. Increased levels of core fucosylation of serum glycoproteins has been correlated with hepatocellular carcinoma. Changes in mucin sialylation have been used to differentiate malignant disease from benign disease states. Lectin profiling platforms have also been used to track changes in inflammatory disease states, congenital disorders of glycosylation, and monitoring glycosylation changes associated with infectious diseases on either host glycoproteins or pathogen derived glycoconjugates. Lectin microarray platforms can also be coupled with mass spectrometry based workflows for glycoproteomics allowing identification of lectin bound proteins with high throughput first pass screening, and structural elucidation for identification.
Orthogonal analytical techniques are often coupled to overcome the limitations imposed by structural complexity of glycans. Chromatographic separation coupled to mass spectrometric detection provides both separation of glycans (for isomers), along with relative quantitation and mass information. Affinity techniques can provide fast screening of glycan motifs with lectins or glycan binding proteins, while HPLC can separate isomers and lectins provide specificity of glycan structures. High-performance liquid chromatography can be used for separation and relative quantitation, while mass spectrometry is used for mass determination and structural analysis. The combination of two or more orthogonal methods provide better confidence of structural assignment, and quantitative information.
The three technologies all have complementary roles in glycan analysis. Chromatography separates glycans by differences in retention time based on hydrophilicity and/or charge allowing determination of relative abundance and number of glucose residues, which can be used as a "fingerprint" for glycans. MS determines the mass of a molecule and structural information can be obtained by fragmenting the glycan further and analyzing the pieces. This allows determination of the monosaccharide composition and linkage information. Lectin arrays allow glycans to be analyzed quickly with little to no sample preparation. The lectins allow for detection of specific glycans and antigens. When using chromatography and MS, results can be confirmed by matching retention times to masses. Results from lectin arrays can be confirmed by showing the presence of a specific glycan epitope using chromatography and MS.
Fig. 2 Glycan profiling of the gut-microbiota by Glycan-seq.2,5
A typical analytical workflow for glycan analysis needs to be designed carefully so that the maximum amount of information can be obtained from limited sample material while still allowing intact samples to pass through as many analysis steps as necessary. Glycoprotein or membrane enriched samples may first be processed to liberate N-glycans, O-glycans or glycolipids. Released glycans can be further processed before they are separated on liquid chromatography systems that are connected directly to mass spectrometers. Separately or as part of the MS analysis glycan samples may be interrogated using lectin arrays to independently confirm glycan motif abundance. Computational strategies are needed to combine retention times, MS data and lectin array data to assign structures to glycans allowing glycosylation patterns to be tracked under different conditions.
Application of multiple methods to profile glycans has been useful for profiling complex biopharmaceutical glycosylation as well as glycans in disease states. Antibody glycosylation has been profiled using high-pH anion exchange chromatography and hydrophilic interaction chromatography (reviewed in Couzigou et al.), lectin microarrays, and combining these methods to provide coverage of neutral and sialylated glycans while confirming galactosylation and fucosylation levels. Profiling of metastatic progression was performed using matrix-assisted laser desorption ionization (MALDI) mass spectrometry of permethylated glycans and solid phase lectin arrays to relate glycan structure to cell surface glycan-binding phenotype. Isomeric high mannose glycans were profiled using reversed-phase chromatography along with tandem mass spectrometry (MS/MS) and MS/MS of permethylated glycans to resolve structures and detect minor components. In these examples, orthogonal data dimensions are brought together to provide information that each technology alone cannot determine.
Benchmarking between glycan analysis platforms allows users to compare the strengths and weaknesses of each technologies' performance including structural coverage, quantitative accuracy, sample throughput, and intended use case. Benchmarking helps users choose what technology is best for their research goals and needs including budget, personnel training, and regulatory needs. Platforms compared include HPLC, MS, and lectin arrays among others useful for laboratory research, drug development, and clinical analysis.
Liquid chromatography differentiates structural isomers based on their retention but needs chemical modification for detection. Mass spectrometry unambiguously gives the molecular weight, and allows for structure elucidation by fragmentation. Thus MS is considered the most accurate technique for de novo sequencing of glycans. Lectin assays can quickly identify motifs but do not give enough structural detail. Often coupling separation methods with detection methods will give complete coverage.
Quantitative analysis of glycans is possible by high-performance liquid chromatography with fluorescence detection since quantitation based on peak area integration is reproducible provided labeling efficiency of each glycan species is equal. Quantitation by mass spectrometry is less straightforward due to unequal ionization efficiencies and matrix effects. Therefore, use of an internal standard is required for mass spectrometry-based quantitation. Lectin arrays can give qualitative to semi-quantitative analysis appropriate for screening purposes. However, they are affected by differences in binding affinity which makes absolute quantitation difficult. Standardization of procedures and inclusion of quality controls are important for obtaining quantitative results for glycans between runs.
With respect to throughput, lectin microarrays are currently at the highest level, allowing hundreds of samples to be interrogated against dozens of binding specificities in a matter of days. Automated sample injection and data collection are possible with high-performance liquid chromatography (HPLC) formats, however throughput is limited due to the long chromatographic separation times. Mass spectrometry may offer fast acquisition times for targeted screening experiments or can take hours for in-depth structural analyses. Platform automation can range from liquid handling robots for sample preparation to API platforms that provide cloud-storage and analysis capabilities.
In discovery research, high information content obtained from hyphenated chromatography/mass spectrometry platforms supports the elucidation of unknown glycans and mechanistic studies. In biopharmaceutical analysis, relative quantitation methods are typically applied for established glycoforms of interest to assure batch-to-batch consistency during method development and validation. Lectin assays are attractive alternatives to MS for clinical laboratories as they require little instrument expertise or sample preparation and provide an affordable way to screen for abnormal glycosylation profiles. Considerations should always be made to determine which analytical methods are most appropriate based on the project needs.
Table 2 Application Domain Suitability Assessment
| Application Domain | Primary Requirements | Preferred Methodologies | Key Considerations |
| Academic research | Structural depth, mechanistic insight | Integrated LC-MS approaches | Comprehensive characterization |
| Biopharmaceutical QC | Reproducibility, regulatory compliance | Validated HPLC methods | Batch consistency monitoring |
| Clinical diagnostics | Speed, cost-effectiveness | Lectin-based assays | Rapid disease screening |
Choice of glycan profiling method will depend on matching available analytical platforms with experimental goals, sample type and availability, and throughput capacity. These factors may include depth of structural information desired, number of samples to be processed, and available resources. This decision will ultimately determine whether chromatography, MS, or affinity will be used or if a combination of techniques will best suit your needs. Considerations are made to choose the method that will provide the appropriate amount of information in a practical manner.
Strategy must ultimately be driven by experimental needs and requirements. If one needs detailed structural information on unknown glycans or new sites of glycosylation for example then an MS platform with fragmentation will be necessary to assist in sequencing and assignment of linkages. If relative quantitation of known glycan biomarkers across numerous samples is needed, then an LC method with fluorescent detection that allows for validated quantitative analysis may be the better route. Fast and specific targeting of glycan motifs for screening purposes can be readily accomplished with lectin-based strategies. Compositional analysis will not require the extensive hardware or resources as a method aimed at determining glycan linkage information.
Sample size, complexity, and availability are important factors to consider when deciding how glycans will be profiled. Small sample size limits the experimental design to platforms with a lower input volume (example: mass spectrometry or microcolumn liquid chromatography) or highly sensitive technologies. High complexity samples with many potential interferents may require methods with high resolving power, as well as enrichment strategies if a subset of glycans are needed. Similarly, the sample throughput desired (ex: high-throughput epidemiological samples vs. low-throughput mechanism-based studies) should be considered when developing a workflow. Lastly, modification stability should be considered when selecting labeling and detection strategies.
Biopharmaceutical production and clinical diagnostics are examples of applied contexts that often have regulatory and quality constraints that can drive method choice. Regulatory requirements have established glycosylation as a quality attribute of therapeutic glycoproteins that must be characterized. Analytical methods for glycosylation profiling in these contexts must be validated with established precision, accuracy, and sensitivity to be used for routine quality control checks. Methods also need defined standard operating procedures, characterized reference standards, cut-offs, and established performance. Furthermore, quality by design concepts require establishing robust methods during method development that can be transferred to another lab and sustained over the lifetime of the product. Clinical diagnostics face requirements for approval or clearance by regulatory bodies as well which may also favor methods that have established clinical utility, quality control parameters, and ease of use during regulatory submissions.
Future glycan profiling platforms will incorporate advances in technology to increase resolution, throughput and accessibility of glycan profiling for a variety of applications. Advances to look for include improvements to separation and detection instrumentation, informatics for unifying diverse datasets of glycan analyses, as well as standardization efforts for reproducible glycomic profiles between labs. All of these avenues of advancement will help increase the capabilities of glycan profiling in regards to the complexity of structures analyzed, throughput of samples, and ease of interpretation to further enable glycomics for therapeutic monitoring and drug development.
Hybrid high resolution chromatography systems using ultra-high pressure liquid chromatography with sub-2-micron particles provide improved separation capabilities for complex glycan mixtures to resolve previously unresolved isomers. Improvements in mass spectrometer designs such as high field mass analyzers and optimized ion mobility spectrometry systems offer higher mass accuracy and capabilities to help distinguish isomers. Detection methods are progressing towards label-free methods with native mass spectrometry detection and advanced optical detectors that allow direct detection without derivatization while retaining the sensitivity needed for biological samples.
Ion mobility spectrometry interfaces are now commonly available for most mass spectrometric platforms. Ion mobility spectrometry affords gas-phase separation in addition to liquid chromatography. Isomeric glycans may therefore be distinguished according to differences in their collision cross sections. In parallel to instrument advances, bioinformatics tools originally developed for database searching are now expanding into machine-learning algorithms that predict glycan structures from fragmentation spectra and correlate multi-omics datasets. Automated approaches to interpretation should decrease analytical run time and increase confidence in glycan assignments by leveraging orthogonal analytical dimensions.
Table 3 Integrative Technologies Enhancing Glycan Profiling Depth
| Integration Approach | Technological Component | Analytical Enhancement |
| Gas-phase separation | Ion mobility spectrometry | Isomer differentiation |
| Data interpretation | Machine learning algorithms | Automated structure prediction |
| Multi-omics integration | Cross-platform bioinformatics | Systems-level glycan context |
Efforts to standardize glycomic analysis are underway to improve reproducibility. Reference materials are being developed, as well as inter-laboratory round robins and standardized methods for glycan release and analysis. Methods using microfluidics and robotic liquid handling are allowing high-throughput glycan analysis of large numbers of samples with limited hands-on time. Such efforts are opening the door to epidemiological studies and clinical diagnostics. Quality controls and standard reporting allow results to be compared between laboratories and experiments.
Choosing an appropriate glycan profiling technique will depend on experimental goals and required sample throughput, as well as how much information you need to obtain about the glycan structures present. For example, HPLC allows differentiation of glycans that are isomers but otherwise cannot determine exact structure, MS will give you exact mass and fragmentation data which can be used to determine glycan structure, lectin arrays/gels are useful for screening glycan motifs quickly. With this being said, there isn't a 'one-size-fits-all' analytical tool for glycomics since structure identification often requires multiple orthogonal approaches to ensure accurate structure identification. Profiling results from chromatography/mass spectrometry that can be backed up with affinity measurements can provide orthogonal data that allows for accurate structure assignment and overall quality control of glycomic data whether it be for basic research, biopharmaceutical characterization or in a clinical setting. With future directions of high throughput and automatable techniques in mind, it is important to use robust techniques that give information about structure and allow for meaningful interpretation of glycomic data.
Comprehensive glycan profiling requires more than access to advanced instrumentation. Reliable glycomics data depends on selecting the appropriate analytical platform, optimizing sample preparation, and interpreting results within a clear biological or biopharmaceutical context. Our glycan profiling services integrate HPLC, mass spectrometry (MS), and lectin-based technologies to deliver accurate, reproducible, and application-driven glycan analysis for research and biopharmaceutical development.
High-quality glycan data begins with a carefully designed analytical strategy. Different glycan profiling techniques provide distinct layers of information:
Translating these analytical outputs into reliable conclusions requires controlled workflows, validated methods, and expert data interpretation. Our approach emphasizes orthogonal validation—combining chromatographic separation, MS fragmentation analysis, and, where appropriate, enzymatic confirmation—to increase structural confidence and reduce ambiguity in glycan assignments.
No single glycan profiling method fits every application. We design customized glycomics workflows tailored to:
Depending on the analytical objective, workflows may include:
By aligning method selection with study goals, sample type, and regulatory expectations, we ensure that glycan profiling delivers actionable insight rather than isolated analytical data.
In glycan analysis, reproducibility and transparency are as critical as analytical sensitivity. Our glycan profiling services incorporate:
For biopharmaceutical applications, glycosylation is often defined as a critical quality attribute (CQA). We support data reporting formats suitable for research documentation, comparability studies, and regulatory submissions, ensuring clarity in structural assignments, quantification strategies, and method validation status.
If you require advanced glycan profiling using HPLC, mass spectrometry, or lectin-based platforms—or need expert guidance in selecting the appropriate analytical strategy—our team provides customized, quality-controlled glycomics solutions. Contact us to discuss your sample type, study objectives, and timeline for comprehensive glycan analysis.
References
